In The News

Dr. Edward S. Kim is a widely respected cancer researcher known for his work on the molecular prognostication of lung cancer. But where his extraordinary brilliance lies is in his executive…

In 2021, the FDA's crack down on accelerated approvals meant the removal of several immunotherapy indications from the US market. In an editorial from FDA faculty members, Julia A. Beaver, MD; and…

Fifty years ago, President Nixon signed the National Cancer Act into law to restructure the country’s way of dealing with a leading cause of death and suffering. Cancer cases were increasing, and a…

Clinical trials provide evidence to support what you do in your work as a nurse every day. They are tools to discover new therapies and identify side effects while considering patient-specific…

The U.S. Supreme Court’s conservatives suggested they are poised to curb abortion rights and uphold Mississippi’s ban on the procedure after 15 weeks of pregnancy, as the court tackled its most…

NEW YORK, Nov. 30, 2021 /PRNewswire/ -- COTA, Inc., an oncology real-world data and analytics company, today announced four of their abstracts will be showcased at the American Society for Hematology…

During its virtual Annual Meeting 2021 held on November 9 and 10, Friends of Cancer Research (Friends) urged all stakeholders in the cancer community to work together to optimize dosing in oncology…

Equitable access to CTs—that is, the opportunity for all patients to access CTs that may offer improved outcomes and the evidence-based standard of care treatment that CTs offer—must be a priority.…

FRIDAY, Nov. 12, 2021 (HealthDay News) -- Despite concerns about his close ties to the drug industry, President Joe Biden is expected on Friday to nominate Dr. Robert Califf, former head of the U.S.…

The White House tapped cardiologist Robert Califf, MD, to once again head the FDA. In a statement formally announcing his decision, President Biden praised Califf's clinical research expertise and…